Cargando…
Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink
The Vaccine Safety Datalink (VSD) conducts active surveillance and vaccine safety research studies. Since the start of the U.S. COVID-19 vaccination program, the VSD has conducted near real-time safety surveillance of COVID-19 vaccines using Rapid Cycle Analysis. VSD investigators developed an inter...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989890/ https://www.ncbi.nlm.nih.gov/pubmed/35428497 http://dx.doi.org/10.1016/j.vaccine.2022.04.010 |
_version_ | 1784683269518786560 |
---|---|
author | Kenigsberg, Tat'Yana A. Hause, Anne M. McNeil, Michael M. Nelson, Jennifer C. Ann Shoup, Jo Goddard, Kristin Lou, Yingbo Hanson, Kayla E. Glenn, Sungching C. Weintraub, Eric S. |
author_facet | Kenigsberg, Tat'Yana A. Hause, Anne M. McNeil, Michael M. Nelson, Jennifer C. Ann Shoup, Jo Goddard, Kristin Lou, Yingbo Hanson, Kayla E. Glenn, Sungching C. Weintraub, Eric S. |
author_sort | Kenigsberg, Tat'Yana A. |
collection | PubMed |
description | The Vaccine Safety Datalink (VSD) conducts active surveillance and vaccine safety research studies. Since the start of the U.S. COVID-19 vaccination program, the VSD has conducted near real-time safety surveillance of COVID-19 vaccines using Rapid Cycle Analysis. VSD investigators developed an internal dashboard to facilitate visualization and rapid reviews of large weekly automated vaccine safety surveillance data. Dashboard development and maintenance was informed by vaccine surveillance data users and vaccine safety partners. Key metrics include population demographics, vaccine uptake, pre-specified safety outcomes, sequential analyses results, and descriptive data on potential vaccine safety signals. Dashboard visualizations are used to provide situational awareness on dynamic vaccination coverage and the status of multiple safety analyses conducted among the VSD population. This report describes the development and implementation of the internal VSD COVID-19 Vaccine Dashboard, including metrics used to develop the dashboard, which may have application across various other public health settings. |
format | Online Article Text |
id | pubmed-8989890 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-89898902022-04-11 Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink Kenigsberg, Tat'Yana A. Hause, Anne M. McNeil, Michael M. Nelson, Jennifer C. Ann Shoup, Jo Goddard, Kristin Lou, Yingbo Hanson, Kayla E. Glenn, Sungching C. Weintraub, Eric S. Vaccine Article The Vaccine Safety Datalink (VSD) conducts active surveillance and vaccine safety research studies. Since the start of the U.S. COVID-19 vaccination program, the VSD has conducted near real-time safety surveillance of COVID-19 vaccines using Rapid Cycle Analysis. VSD investigators developed an internal dashboard to facilitate visualization and rapid reviews of large weekly automated vaccine safety surveillance data. Dashboard development and maintenance was informed by vaccine surveillance data users and vaccine safety partners. Key metrics include population demographics, vaccine uptake, pre-specified safety outcomes, sequential analyses results, and descriptive data on potential vaccine safety signals. Dashboard visualizations are used to provide situational awareness on dynamic vaccination coverage and the status of multiple safety analyses conducted among the VSD population. This report describes the development and implementation of the internal VSD COVID-19 Vaccine Dashboard, including metrics used to develop the dashboard, which may have application across various other public health settings. Elsevier Science 2022-05-11 2022-04-08 /pmc/articles/PMC8989890/ /pubmed/35428497 http://dx.doi.org/10.1016/j.vaccine.2022.04.010 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Kenigsberg, Tat'Yana A. Hause, Anne M. McNeil, Michael M. Nelson, Jennifer C. Ann Shoup, Jo Goddard, Kristin Lou, Yingbo Hanson, Kayla E. Glenn, Sungching C. Weintraub, Eric S. Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink |
title | Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink |
title_full | Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink |
title_fullStr | Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink |
title_full_unstemmed | Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink |
title_short | Dashboard development for near real-time visualization of COVID-19 vaccine safety surveillance data in the Vaccine Safety Datalink |
title_sort | dashboard development for near real-time visualization of covid-19 vaccine safety surveillance data in the vaccine safety datalink |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989890/ https://www.ncbi.nlm.nih.gov/pubmed/35428497 http://dx.doi.org/10.1016/j.vaccine.2022.04.010 |
work_keys_str_mv | AT kenigsbergtatyanaa dashboarddevelopmentfornearrealtimevisualizationofcovid19vaccinesafetysurveillancedatainthevaccinesafetydatalink AT hauseannem dashboarddevelopmentfornearrealtimevisualizationofcovid19vaccinesafetysurveillancedatainthevaccinesafetydatalink AT mcneilmichaelm dashboarddevelopmentfornearrealtimevisualizationofcovid19vaccinesafetysurveillancedatainthevaccinesafetydatalink AT nelsonjenniferc dashboarddevelopmentfornearrealtimevisualizationofcovid19vaccinesafetysurveillancedatainthevaccinesafetydatalink AT annshoupjo dashboarddevelopmentfornearrealtimevisualizationofcovid19vaccinesafetysurveillancedatainthevaccinesafetydatalink AT goddardkristin dashboarddevelopmentfornearrealtimevisualizationofcovid19vaccinesafetysurveillancedatainthevaccinesafetydatalink AT louyingbo dashboarddevelopmentfornearrealtimevisualizationofcovid19vaccinesafetysurveillancedatainthevaccinesafetydatalink AT hansonkaylae dashboarddevelopmentfornearrealtimevisualizationofcovid19vaccinesafetysurveillancedatainthevaccinesafetydatalink AT glennsungchingc dashboarddevelopmentfornearrealtimevisualizationofcovid19vaccinesafetysurveillancedatainthevaccinesafetydatalink AT weintrauberics dashboarddevelopmentfornearrealtimevisualizationofcovid19vaccinesafetysurveillancedatainthevaccinesafetydatalink |